ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

计划入组 120 人 · 首次发布于 2025 年 4 月 7 日

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

计划入组 145 人 · 首次发布于 2021 年 5 月 25 日

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

计划入组 116 人 · 首次发布于 2026 年 4 月 7 日

HPV 16 E7/HSP70 DNA vaccine

Sig-HELP-E7SH-kdel

HPV-T

DNA International Hospital

Vietnam

Stiftung Swiss Tumor Institute

Switzerland

National Center for Tumor Diseases

Germany

Ultrasensitive Blood Test HPV-DeepSeek Predicts Recurrence and Survival in HPV-Associated Head and Neck Cancer

Naveris Showcases NavDx Test Advances for HPV-Associated Oropharyngeal Cancer Surveillance at ASTRO 2024

Toragen's TGN-S11 Shows Early Promise in HPV-Associated Cancers